Nina D. Wagner-Johnston, MD

Articles by Nina D. Wagner-Johnston, MD

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Elevating the Quality of Cancer Care via Cross-Department Collaboration

ByRachit Kumar, MD,Michael J. Pishvaian, MD, PhD,Nina D. Wagner-Johnston, MD,Valerie Lee, MD,Armine K. Smith, MD,Pouneh Razavi, MD,Curtiland Deville Jr., MD

April 7th 2025

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

The Importance of Multidisciplinary Care in Bone Marrow Transplantation

ByNina D. Wagner-Johnston, MD

April 3rd 2025

Multidisciplinary care is important for all cancer care, specifically bone marrow transplant, stated Nina Wagner-Johnston, MD.

Immunotherapy Plus Transplantation Improves Outcomes in Relapsed Lymphoma

ByNina D. Wagner-Johnston, MD

April 2nd 2025

“Recognizing that we could follow immunotherapy with a bone marrow transplant safely was quite important,” Nina Wagner-Johnston, MD, stated.

Something Old, Something New: Options for Treating Relapsed Mantle Cell Lymphoma

ByNina D. Wagner-Johnston, MD,Nancy L. Bartlett, MD

July 17th 2009

Dr. Ruan and colleagues provide an excellent summary of available treatment options, as well as new drugs on the horizon, for the management of relapsed mantle cell lymphoma (MCL). As the authors emphasize, treatment of relapsed MCL is strongly influenced by the patient’s first-line therapy and needs to be individualized based on both patient and disease characteristics.